Indications : התוויות

4.1      Therapeutic indications
Non-Small Cell Lung Cancer:
Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion is indicated for the palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer.

Breast Cancer:
Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion in combination with paclitaxel is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.
Prior chemotherapy should have included an anthracycline unless clinically contraindicated.

Pancreatic Cancer:
Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.

Bladder Cancer:
Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion is indicated for the treatment of patients with bladder cancer at the invasive stage.

Ovarian Cancer:
Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma who have relapsed at least 6 months after platinum-based therapy.